A detailed history of Pnc Financial Services Group, Inc. transactions in Rezolute, Inc. stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 188 shares of RZLT stock, worth $1,863. This represents 0.0% of its overall portfolio holdings.

Number of Shares
188
Holding current value
$1,863
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Nov 07, 2025

BUY
$4.42 - $9.34 $830 - $1,755
188 New
188 $1,000
Q2 2021

Aug 06, 2021

BUY
$6.11 - $15.99 $4,582 - $11,992
750 New
750 $0

Others Institutions Holding RZLT

About Rezolute, Inc.


  • Ticker RZLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,600
  • Market Cap $385M
  • Description
  • Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...
More about RZLT
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.